Transoma Medical Inc., a St. Paul, Minn.-based maker of implantable wireless vital sign monitors, has set its IPO terms to four million common shares being offered at between $14 and $16 per share. It would have an initial market cap of approximately $290 million, were it to price at the high end of its range.
Transoma plans to trade on the Nasdaq under ticker symbol TSMA, with Piper Jaffray and Thomas Weisel Partners serving as co-lead underwriters. Transoma has raised just over $38 million in total VC funding, from firms like Polaris Venture Partners (24.47% pre-IPO stake), Canaan Partners (20%), Affinity Capital Management and Cross Creek Capital.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.